Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study |
Type de publication | Journal Article |
Year of Publication | 2018 |
Auteurs | Allaire M, Cadranel J-FD, Bureau C, Zerkly S, Thevenot T, Garioud A, Cacoub P, Macaigne G, Alric L, Jouannaud V, Lison H, Chagneau-Derrode C, Pariente A, Pelaquier A, Bourliere M, Causse X, Nousbaum J-B, Dumortier J, Louvet A, Rosa-Hezode I, Ganne-Carrie N, Chentouh R, Sfaxi A, Gournay J, Blasco-Perrin H, Antonini T, Spahr L, Bronowicki J-P, Silvain C, Di Martino V, Grange J-D, Denis J, Dupont K, Iaria P, Ollivier-Hourmand I, Dao T, Gastroenterologist FAssoc |
Journal | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
Volume | 30 |
Pagination | 1216-1223 |
Date Published | OCT |
Type of Article | Article |
ISSN | 0954-691X |
Mots-clés | Cardiac surgery, case-control study, cirrhosis, infectious endocarditis, prognostic factors |
Résumé | {BackgroundData on infectious endocarditis (IE) in patients with liver cirrhosis (LC) are sparse. We aimed to describe the characteristics and predictors of mortality from IE in patients with LC.Patients and methodsOverall, 101 patients with LC and 101 controls with IE matched for sex, age, date of IE, and diabetes were retrospectively selected in 23 liver units between 2000 and 2013.ResultsMean age was 60.810.5 and 60.6 +/- 11.5 years in LC and controls, respectively. Causes of cirrhosis (Child-Pugh A/B/C: 10.4%/41.7%/47.9%, MELD score: 17 +/- 7.8) were excess alcohol intake (79.6%), viral hepatitis (17.3%), and metabolic syndrome (14.3%). Previous history of cardiopathy was found in 24.8% of LC (prosthetic valve 8.9%) and 37.6% of controls (P=0.07). The most frequent bacteria involved were gram-positive cocci. LC had significantly fewer aminoglycosides (P=0.0007), rifamycin (P=0.03), and valve surgery (P=0.02) than controls. The proportion of patients who died following cardiac surgery was similar between the two groups (9.7% for LC vs. 8.7% for controls |
DOI | 10.1097/MEG.0000000000001155 |